These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 1671642)

  • 1. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells.
    Horio M; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1988 May; 85(10):3580-4. PubMed ID: 3368466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein.
    Cornwell MM; Pastan I; Gottesman MM
    J Biol Chem; 1987 Feb; 262(5):2166-70. PubMed ID: 2434476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies of P-glycoprotein in inside-out plasma membrane vesicles derived from murine erythroleukemia cells overexpressing MDR 3. Properties and kinetics of the interaction of vinblastine with P-glycoprotein and evidence for its active mediated transport.
    Schlemmer SR; Sirotnak FM
    J Biol Chem; 1994 Dec; 269(49):31059-66. PubMed ID: 7983045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.
    Höllt V; Kouba M; Dietel M; Vogt G
    Biochem Pharmacol; 1992 Jun; 43(12):2601-8. PubMed ID: 1352973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.
    Doige CA; Sharom FJ
    Biochim Biophys Acta; 1992 Aug; 1109(2):161-71. PubMed ID: 1355667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.
    Cornwell MM; Gottesman MM; Pastan IH
    J Biol Chem; 1986 Jun; 261(17):7921-8. PubMed ID: 3711117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP and GTP as alternative energy sources for vinblastine transport by P-170 in KB-V1 plasma membrane vesicles.
    Lelong IH; Padmanabhan R; Lovelace E; Pastan I; Gottesman MM
    FEBS Lett; 1992 Jun; 304(2-3):256-60. PubMed ID: 1352260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.
    Horio M; Chin KV; Currier SJ; Goldenberg S; Williams C; Pastan I; Gottesman MM; Handler J
    J Biol Chem; 1989 Sep; 264(25):14880-4. PubMed ID: 2570070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein to a cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine.
    Ferry D; Boer R; Callaghan R; Ulrich WR
    Int J Clin Pharmacol Ther; 2000 Mar; 38(3):130-40. PubMed ID: 10739116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
    Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
    J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
    Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.
    Sinicrope FA; Dudeja PK; Bissonnette BM; Safa AR; Brasitus TA
    J Biol Chem; 1992 Dec; 267(35):24995-5002. PubMed ID: 1360981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
    Abraham I; Wolf CL; Sampson KE
    Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
    Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
    Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinblastine transport by membrane vesicles from human multidrug-resistant CCRF-CEM leukaemia cells: inhibition by taxol and membrane permeabilising agents.
    Syed SK; Christopherson RI; Roufogalis BD
    Biochem Mol Biol Int; 1993 Jul; 30(4):743-53. PubMed ID: 8104621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.